Navigation Links
Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function
Date:6/1/2008

TORONTO, June 1 /PRNewswire/ -- The final results of the Spare the Nephron (STN) study, a multicenter trial investigating a novel kidney-sparing treatment protocol using CellCept(R) (mycophenolate mofetil), showed the CellCept-based regimen in combination with sirolimus (SRL) is associated with improved renal function when compared with the CellCept-based regimen in combination with calcineurin inhibitors (CNI).

Furthermore, the study showed this improvement without increasing the risk of acute rejection, and was tolerated in almost 80 percent of patients. The results were presented today at the American Transplant Congress (ATC) in Toronto.

The STN Trial in kidney transplant recipients examines ways to prevent rejection without damaging kidneys. As transplant patients are living longer, studies suggest that therapies such as CNIs can cause impairment of kidney function, damage to the blood vessels, and filtering capacity of the kidneys. "This study provides strong evidence for the benefits of a CNI-free, CellCept-based regimen," said Thomas Pearson, M.D., lead investigator, Livingston Professor of Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, GA.

The STN trials were conducted at more than 35 transplant centers in the United States and Canada.

"The goal of this study was to optimize the use of immunosuppressants for achieving long-term success," added Dr. Pearson. "The STN Kidney studied the combination of CellCept and SRL with the goal of reducing CNI associated nephrotoxicity therapy to prolong graft and patient survival."

About the Study

This open-label, prospective, multicenter study, randomized 305 patients (maintained on MMF and a CNI) for 30-180 days post-transplant to receive either MMF (1-1.5 g BID) plus SRL (2-10 mg followed by at least 2 mg/day; trough 5-10 ng/mL) and discontinue the CNI (MMF/SRL) or to continue their current regimen (MMF/CNI). Antibody induction and/or corti
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. The Anatomy of Clinical Trials: Greys Season Finale Leaves Public in the Dark About the Myths and Realities
2. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
3. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
4. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
5. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
6. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
7. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
8. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
9. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
10. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
11. BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 5, 2015 CANTEL MEDICAL CORP. (NYSE: ... ended January 31, 2015 on Thursday, March 12 before the ... results at 11:00 AM ET. To participate ... 10 minutes before the beginning of the call. If you ... will be available from Thursday, March 12, 2015 through midnight ...
(Date:3/5/2015)... , March 5, 2015  Sanomedics, Inc. (OTC: ... technology company focused on developing, manufacturing, and acquiring cutting-edge ... subsidiary, Thermomedics, Inc., will be exhibiting at booth # ... Practitioners Conference (NAPNAP) taking place on March 11-13, ... NV. The 36 th ...
(Date:3/5/2015)... , March 5, 2015   ndd Medical ... testing (PFT) that employs precise ultrasound technology, announced that ... event held by the San Antonio Pulmonary Fibrosis Support ... (ILD) or pulmonary fibrosis (PF), as well as those ... a footprint of a mere 12 square inches, EasyOne ...
Breaking Medicine Technology:Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 3
(Date:3/5/2015)... 05, 2015 HMP Communications ... communications and education, announced today its acquisition of ... nation’s only medical conference designed for health care ... lower limb amputation due to vascular disorders. ... innovative, evidence-based publications and CME activities across therapeutic ...
(Date:3/5/2015)... Anaheim, Calif. (PRWEB) March 05, 2015 ... plant-powered beverages, today announced at Natural Products Expo West ... drinks are now 100 percent soy and dairy free. ... 10.5-ounce single serve bottle and are packed with six ... rice protein that includes fiber, B vitamins and magnesium. ...
(Date:3/5/2015)... Los Angeles, Calif. (PRWEB) March 05, 2015 ... company and the leader in the natural products coffee ... Coffee at Natural Products Expo West in Anaheim, Calif. ... Califia’s home café concept, Califia Café, which democratizes the ... drinkers all the ingredients they need to become their ...
(Date:3/5/2015)... 05, 2015 University of Western ... in 1904, has launched a new center of ... changes. The Northwest Center for Lifestyle and Functional ... community outreach, and conduct research in the areas ... and nutrition. The center will target efforts on ...
(Date:3/5/2015)... Frisco, TX (PRWEB) March 05, 2015 ... Convention Center in Fort Worth, Texas April 9-11th ... and wellness company providing personalized nutrition. IDLife ... core product, IDNutrition. This customized approach to ... research that begins with a free HIPAA compliant ...
Breaking Medicine News(10 mins):Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2Health News:IDLife Partners John C. Maxwell and Troy Aikman speaking at IDRevolution in Fort Worth, TX April 9th-11th, 2015 2
... , , FRAMINGHAM, Mass., ... HTWR ) (ASX: HIN) announced today the completion of its offering ... private placement in the United States and Australia (the "Offerings"). ... of US$22.00 per share resulting in gross proceeds of approximately US$60 ...
... records points to an epidemic at the time, , MONDAY, ... of classical music: What -- or who -- killed Mozart at ... his creative powers? , Now, there,s a new theory: He died ... inherent drama of murder by a rival or suicide, which have ...
... Aug. 17 Insulet Corporation (Nasdaq: PODD ), the ... Management System, today announced the appointment of Peter J. Devlin ... Devlin will lead the Company,s Sales and Marketing, Business Development, ... "Peter brings a distinguished track record in the diabetes ...
... mortality risk, study suggests , MONDAY, Aug. 17 (HealthDay ... the risk of death among people with peripheral arterial ... when plaque accumulates in arteries that supply blood to ... brain. , The study included 184 PAD patients, average ...
... common vitamin and mineral supplements, , MONDAY, Aug. 17 (HealthDay ... increase the risk for melanoma, the most serious form of ... had suggested that the risk for melanoma was increased four-fold ... carotene, selenium and zinc. Because 48 to 55 percent of ...
... , , ALBANY, N.Y., ... (NYSDOT) announced that tomorrow, August 18, 2009, will be an ... be unhealthy, especially for sensitive individuals, such as children, seniors ... forecasted high levels of both particulate matter and ground-level ozone ...
Cached Medicine News:Health News:HeartWare International, Inc. Closes US$60 Million Financing 2Health News:HeartWare International, Inc. Closes US$60 Million Financing 3Health News:Strep Throat May Have Led to Mozart's Death 2Health News:Strep Throat May Have Led to Mozart's Death 3Health News:Insulet Appoints Peter J. Devlin as Chief Commercial Officer 2Health News:Worries May Worsen Peripheral Arterial Disease 2Health News:Antioxidants Pose No Melanoma Threat 2Health News:Antioxidants Pose No Melanoma Threat 3Health News:Air Quality Action Day Declared for Tuesday, August 18, 2009 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: